Zhang Chun-Lin

11PUBLICATIONS
10CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Regenerative medicine (incl. stem cells)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Nov 01, 2026
The serotonin axis in cancer: metabolism, epigenetics, and immune regulation.

|Sep 03, 2026
Coordinated circRNA Silencing and Chemotherapy by pH-Responsive Nanoparticles Reprogram Cell Death in Drug-Resistant Osteosarcoma.

|Mar 17, 2026
Efficacy of Ultrasonic Scalpel in Orthopaedic Oncology Surgery: An Initial Patient Cohort Study Based on Propensity Score Matching Analysis.

Jianping Hu, Jiazhuang Zhu, Zhen Huang

|May 19, 2025
Activation of HTR2B Suppresses Osteosarcoma Progression through the STAT1-NLRP3 Inflammasome Pathway and Promotes OASL1+ Macrophage Production to Enhance Antitumor Immunity.

Zhen Huang, Jiazhuang Zhu, Jianping Hu

|Jan 27, 2025
Advances in understanding the role of squalene epoxidase in cancer prognosis and resistance.

Jiazhuang Zhu, Yongjie Wang, Kunpeng Zhu

|Feb 19, 2024
Identifying squalene epoxidase as a metabolic vulnerability in high-risk osteosarcoma using an artificial intelligence-derived prognostic index.

Yongjie Wang, Xiaolong Ma, Enjie Xu

Pageof 2

Frequent Collaborators

3 joint publications

Kunpeng Zhu

2 joint publications

Jianping Hu

2 joint publications

Yongjie Wang

1 joint publications

Yunlu Dai